Abstract

Omental cancer, often associated with peritoneal carcinomatosis, is characterized by malignant tumors that primarily affect the omentum, a fold of peritoneum extending from the stomach. The condition is frequently secondary to cancers of the gastrointestinal tract, particularly ovarian and gastric cancers. The clinical presentation varies, but patients often experience abdominal pain, distension, and changes in bowel habits. Diagnosis typically involves imaging studies such as CT scans and laparoscopy, which aid in identifying omental masses. Current treatment approaches include surgical intervention, often with omentectomy, and systemic chemotherapy. However, the prognosis remains poor due to latestage diagnosis and the aggressive nature of the disease. Recent advances in targeted therapies and immunotherapy offer hope for improving outcomes, but further research is needed to understand the biological mechanisms underlying omental cancer and to develop more effective therapeutic strategies